Thanks to ongoing research and development in pharmaceuticals, the sector is benefitting from ongoing innovation which is helping break new boundaries in healthcare. Lu Rahman explains.
The thought that counts
The decline of the blockbuster drug means that pharmaceutical companies have been keen to exploit new revenue streams and opportunities. Innovation has become key to the continued success of businesses involved in the manufacture of drugs and medicines. And while the market may not be flooded with single molecule launches, the industry is at the forefront of new healthcare processes and systems which are already becoming potential game changers in the pharmaceutical supply chain.